Solésence, Inc. was named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards, recognizing its excellence in client satisfaction, innovation, product development, and speed-to-market. The award highlights Solésence's leadership in scientifically-driven health care solutions in beauty and life sciences, with a strong focus on skin health and environmental protection technologies. This recognition follows 12 industry awards since 2022 and supports the company's plans to expand its innovative platform into active skin restoration. Solésence aims to continue delivering patent-backed innovations that meet evolving consumer demands and accelerate product development for its brand partners.
ARCpoint Inc. has been issued a failure-to-file cease trade order by the British Columbia Securities Commission due to missing its July 29, 2026 deadline to file audited annual financial statements and related documents for the year ended March 31, 2...
Tarsus Pharmaceuticals announced it will host a live webcast on August 6, 2026, to report its second quarter financial results and provide a corporate update. The webcast will be available at 5:00 a.m. PT / 8:00 a.m. ET, with a recorded version acces...
Kirby McInerney LLP is investigating Myriad Genetics for possible securities fraud following the company's report of an 11% revenue decline in Q2 2026 and a lowered full-year revenue forecast. The company also disclosed an $11 million revenue reducti...
Kirby McInerney LLP is investigating Dr. Reddy's Laboratories for possible securities fraud following the company's Q1 fiscal 2027 earnings report, which revealed an earnings miss and a ₹2.4 billion provision related to out-of-spec semaglutide batche...
Jefferies Financial Group is under investigation by Kirby McInerney LLP for potential securities law violations related to its asset-management unit's exposure to First Brands Group, which declared bankruptcy in 2025. The SEC is reportedly probing wh...
